Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

24432 ARTÍCULOS , VIENDO DEL 2701 AL 2715

Unlocking early detection of Alzheimer's disease: The emerging role of nanomaterial-based optical sensors

Chen CH, Liang HH, Wang CC, Yang YT, Lin YH, Chen YL.

J Food Drug Anal. 2024 Sep 13;32(3):296-324. doi: 10.38212/2224-6614.3520.

Medication Exposure and Risk of Dementia and Alzheimer's Disease

Sharma N, An SSA, Kim SY.

Int J Mol Sci. 2024 Nov 29;25(23):12850. doi: 10.3390/ijms252312850.

Role of Blood P-Tau Isoforms (181, 217, 231) in Predicting Conversion from MCI to Dementia Due to Alzheimer's Disease: A Review and Meta-Analysis

Lombardi G, Pancani S, Manca R, Mitolo M, Baiardi S, Massa F, Coppola L, Franzese M, Nicolai E, Guerini FR, Mancuso R, Agliardi C, Agostini S, Pardini M, Virgili G, Sorbi S, Parchi P, Nacmias B, Venneri A.

Int J Mol Sci. 2024 Nov 30;25(23):12916. doi: 10.3390/ijms252312916.

[Research progress of MCP-1 in the pathogenesis of Alzheimer's disease]

Xu Y, Li Q, Mao S, Yang K, Yang S.

Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2024 Dec;40(12):1115-1120.

Advances in Alzheimer's Disease Biomarkers

Li K, Gao Y, Liu M, Chen Y.

Curr Alzheimer Res. 2024;21(11):791-803. doi: 10.2174/0115672050366767241223050957.

Understanding the Molecular Impact of Physical Exercise on Alzheimer's Disease

Cantón-Suárez A, Sánchez-Valdeón L, Bello-Corral L, Cuevas MJ, Estébanez B.

Int J Mol Sci. 2024 Dec 18;25(24):13576. doi: 10.3390/ijms252413576.

Head-to-Head Comparison of Aptamer- and Antibody-Based Proteomic Platforms in Human Cerebrospinal Fluid Samples from a Real-World Memory Clinic Cohort

Puerta R, Cano A, García-González P, García-Gutiérrez F, Capdevila M, de Rojas I, Olivé C, Blázquez-Folch J, Sotolongo-Grau O, Miguel A, Montrreal L, Martino-Adami P, Khan A, Orellana A, Sung YJ, Frikke-Schmidt R, Marchant N, Lambert JC, Rosende-Roca M, Alegret M, Fernández MV, Marquié M, Valero S, Tárraga L, Cruchaga C, Ramírez A, Boada M, Smets B, Cabrera-Socorro A, Ruiz A.

Int J Mol Sci. 2024 Dec 31;26(1):286. doi: 10.3390/ijms26010286.

The Role of Neuroglial Metabotropic Glutamate Receptors in Alzheimer's Disease

Abd-Elrahman KS, Sarasija S, Ferguson SSG.

Curr Neuropharmacol. 2023;21(2):273-283. doi: 10.2174/1570159X19666210916102638.

The Implication of Glial Metabotropic Glutamate Receptors in Alzheimer's Disease

de Lima IBQ, Ribeiro FM.

Curr Neuropharmacol. 2023;21(2):164-182. doi: 10.2174/1570159X20666211223140303.

The Current Evidence for the Therapeutic Role of Curcumin in Alzheimer's Disease

Bland AR, Ashton JC, Kamal MA, Sahebkar A.

CNS Neurol Disord Drug Targets. 2023;22(3):318-320. doi: 10.2174/1871527321666220119105836.

Impact of the Cannabinoid System in Alzheimer's Disease

Li S, Huang Y, Yu L, Ji X, Wu J.

Curr Neuropharmacol. 2023;21(3):715-726. doi: 10.2174/1570159X20666220201091006.

Selenium-Derivative Compounds: A Review of New Perspectives in the Treatment of Alzheimer's Disease

Barbosa FAR, Canto RFS, Teixeira KF, de Souza AS, de Oliveira AS, Braga AL.

Curr Med Chem. 2023;30(6):689-700. doi: 10.2174/0929867329666220224161454.

Epigenetic Modifications by Estrogen and Androgen in Alzheimer's Disease

Kumar R, Fatima F, Yadav G, Singh S, Haldar S, Alexiou A, Ashraf GM.

CNS Neurol Disord Drug Targets. 2023;22(1):6-17. doi: 10.2174/1871527321666220225110501.

Role of Oxysterols in the Activation of the NLRP3 Inflammasome as a Potential Pharmacological Approach in Alzheimer's Disease

Martins GL, Ferreira CN, Palotás A, Rocha NP, Reis HJ.

Curr Neuropharmacol. 2023;21(2):202-212. doi: 10.2174/1570159X20666220327215245.

Nanotechnology: A Promising Targeted Drug Delivery System for Brain Tumours and Alzheimer's Disease

Unnisa A, Greig NH, Kamal MA.

Curr Med Chem. 2023;30(3):255-270. doi: 10.2174/0929867329666220328125206.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias